A carregar...
Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
Tumour biomarker status is being used more and more frequently to guide treatment decisions in patients with metastatic colorectal cancer (mCRC). Continued cycles of hypothesis generation and biomarker testing in retrospective, prospective–retrospective and prospective analyses from studies of the e...
Na minha lista:
| Publicado no: | Drugs |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419154/ https://ncbi.nlm.nih.gov/pubmed/25895463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-015-0386-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|